OCGN
0.75 USD
+0.00%
Today
+1.35%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Ocugen Inc
Currency
USD
Market Cap
252.71M
Avg Daily Volume
6.54M
52 Week High
2.725 USD
52 Week Low
0.691 USD
Trading Hours
See hours
Business Summary
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is involved in the development of OCU200, a novel recombinant fusion protein for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
Top News
Ocugen
+10.96%
Ocugen Reports $1.95 Million Revenue and $3.6 Million Net Loss for Q3 2026
tradingview.com
50m ago
Ocugen
+10.96%
OCGN: OCU400 advances toward 2027 data with expanded licensing and runway into 2028
tradingview.com
2h ago
Ocugen
+10.96%
IWB_CFD
+1.14%
UMB_Financial
-0.91%
Glaukos
+0.53%
Veritone
+3.85%
Accendra.Health
+4.35%
AREC
-1.72%
Anavex
-2.59%
Eyepoint.Pharmaceuticals
+8.57%
Heron
+0.00%
Invivyd
+3.70%
Karyopharm
+0.00%
Optimum.Communication
+3.45%
Oscar.Health
+9.52%
PLBY_Group
+3.10%
Wheelsup
+0.96%
Voyager.Therapeutics
+6.40%
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
tradingview.com
5d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
